Literature DB >> 32362586

Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs.

Emily R Leff1, Seksiri Arttamangkul1, John T Williams2.   

Abstract

Based on studies using mutations of the µ-opioid receptor (MOR), phosphorylation of multiple sites on the C-terminus has been recognized as a critical step underlying acute desensitization and the development of cellular tolerance. The aim of this study is to explore which kinases mediate desensitization of MOR in brain slices from drug-naïve and morphine-treated animals. Whole-cell recordings from locus coeruleus neurons were made, and the agonist-induced increase in potassium conductance was measured. In slices from naïve animals, pharmacological inhibition of G-protein receptor kinase (GRK2/3) with compound 101 blocked acute desensitization. Following chronic treatment with morphine, compound 101 was less effective at blocking acute desensitization. Compound 101 blocked receptor internalization in tissue from both naïve and morphine-treated animals, suggesting that GRK2/3 remained active. Kinase inhibitors aimed at blocking protein kinase C and c-Jun N-terminal kinase had no effect on desensitization in tissue taken from naïve animals. However, in slices taken from morphine-treated animals, the combination of these blockers along with compound 101 was required to block acute desensitization. Acute desensitization of the potassium conductance induced by the somatostatin receptor was also blocked by compound 101 in slices from naïve but not morphine-treated animals. As was observed with MOR, it was necessary to use the combination of kinase inhibitors to block desensitization of the somatostatin receptor in slices from morphine-treated animals. The results show that chronic treatment with morphine results in a surprising and heterologous adaptation in kinase-dependent desensitization. SIGNIFICANCE STATEMENT: The results show that chronic treatment with morphine induced heterologous adaptations in kinase regulation of G protein coupled receptor (GPCR) desensitization. Although the canonical mechanism for acute desensitization through phosphorylation by G protein-coupled receptor kinase is supported in tissue taken from naïve animals, following chronic treatment with morphine, the acute kinase-dependent desensitization of GPCRs is disrupted such that additional kinases, including protein kinase C and c-Jun N-terminal kinase, contribute to desensitization.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32362586      PMCID: PMC7562982          DOI: 10.1124/mol.119.119362

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  36 in total

1.  Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.

Authors:  Bo Feng; Zhihua Li; Jia Bei Wang
Journal:  Mol Pharmacol       Date:  2011-01-06       Impact factor: 4.436

2.  Opioid desensitization: interactions with G-protein-coupled receptors in the locus coeruleus.

Authors:  C D Fiorillo; J T Williams
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

3.  Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.

Authors:  William T Birdsong; Seksiri Arttamangkul; James R Bunzow; John T Williams
Journal:  Mol Pharmacol       Date:  2015-05-01       Impact factor: 4.436

4.  Arrestin-3 binds c-Jun N-terminal kinase 1 (JNK1) and JNK2 and facilitates the activation of these ubiquitous JNK isoforms in cells via scaffolding.

Authors:  Seunghyi Kook; Xuanzhi Zhan; Tamer S Kaoud; Kevin N Dalby; Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  J Biol Chem       Date:  2013-11-20       Impact factor: 5.157

5.  Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization.

Authors:  Javier Garzón; María Rodríguez-Muñoz; Almudena López-Fando; Pilar Sánchez-Blázquez
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

6.  Evidence that behavioral phenotypes of morphine in β-arr2-/- mice are due to the unmasking of JNK signaling.

Authors:  Nitish Mittal; Miao Tan; Onyemachi Egbuta; Nina Desai; Cynthia Crawford; Cui-Wei Xie; Christopher Evans; Wendy Walwyn
Journal:  Neuropsychopharmacology       Date:  2012-04-11       Impact factor: 7.853

Review 7.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

8.  Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization.

Authors:  Ji Chu; Hui Zheng; Yuhan Zhang; Horace H Loh; Ping-Yee Law
Journal:  Cell Signal       Date:  2010-01-05       Impact factor: 4.315

9.  Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase.

Authors:  Selena S Schattauer; Benjamin B Land; Kathryn L Reichard; Antony D Abraham; Lauren M Burgeno; Jamie R Kuhar; Paul E M Phillips; Shao En Ong; Charles Chavkin
Journal:  Nat Commun       Date:  2017-09-29       Impact factor: 14.919

10.  Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.

Authors:  A Kliewer; F Schmiedel; S Sianati; A Bailey; J T Bateman; E S Levitt; J T Williams; M J Christie; S Schulz
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 17.694

View more
  6 in total

1.  Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons.

Authors:  Xinyi Jenny He; Janki Patel; Connor E Weiss; Xiang Ma; Brenda L Bloodgood; Matthew R Banghart
Journal:  Elife       Date:  2021-11-17       Impact factor: 8.140

Review 2.  Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System.

Authors:  Sweta Adhikary; John T Williams
Journal:  Front Syst Neurosci       Date:  2022-06-28

3.  Changes in the development of opioid tolerance on re-exposure among people who use heroin: A qualitative study.

Authors:  Joanna May Kesten; Ed Holder; Rachel Ayres; Pete Ellis; Steve Taylor; Matthew Hickman; Graeme Henderson
Journal:  PLoS One       Date:  2022-06-23       Impact factor: 3.752

Review 4.  Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?

Authors:  Laura J Gledhill; Anna-Marie Babey
Journal:  Cell Mol Neurobiol       Date:  2021-03-11       Impact factor: 5.046

Review 5.  Recent advances in basic science methodology to evaluate opioid safety profiles and to understand opioid activities.

Authors:  Aliza T Ehrlich; Emmanuel Darcq
Journal:  Fac Rev       Date:  2021-02-19

Review 6.  Cellular and circuit diversity determines the impact of endogenous opioids in the descending pain modulatory pathway.

Authors:  Kylie B McPherson; Susan L Ingram
Journal:  Front Syst Neurosci       Date:  2022-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.